We have previously reported that E2 inhibits colitis-associated tumorigenesis (14) and that Nrf2 deficiency enhances the anti-tumorigenic effect of E2 (23) in an AOM/DSS model of CAC. The gene discussed is NFE2L2; the disease is colitis.